Connected Healthcare and Internet of Medical Things Market Outlook 2026–2034: Market Size, Growth Drivers, Key Players, Strategic Developments & Adoption Forecast for Remote Monitoring, Hospital-at-Home, Smart Hospitals and AI-Enabled Care — A Meticulous Next™ Foresight Brief

This Meticulous Next™ brief examines how the Internet of Medical Things (IoMT), including connected medical devices, sensors, wearables, and the platforms and AI systems that analyze their data, will reshape healthcare delivery over the next 5–10 years. By enabling continuous monitoring of physiological, behavioral, and operational data, IoMT is supporting a shift from episodic care toward more connected, predictive, and patient-centered care models.

Traditional healthcare systems are largely built around clinical visits. Patients are assessed, treated, and discharged, with limited visibility into their condition between encounters. Connected devices help bridge this gap by continuously monitoring health status, detecting early signs of deterioration, supporting care delivery outside traditional clinical settings, and extending clinical oversight into the home and community. At the same time, hospitals are becoming increasingly connected environments where devices, systems, and workflows generate real time data that can support operational and clinical decision making.

The brief examines the technology landscape, indicative market size and growth outlook, major growth drivers, significant developments over the past 24 months, leading companies active in the space, and the expected adoption pathway through 2034.

This focused 105 page decision brief is intended for health system and hospital executives, clinical and nursing leaders, payers, medical device manufacturers, consumer health companies, health IT providers, platform vendors, connectivity and cybersecurity providers, regulators, and investors. It presents an indicative market trajectory rather than a segmented market model. The objective is to identify which care models and healthcare settings are most likely to transition toward connected and continuous care first, how devices, data, and AI are converging into integrated care platforms, and where value is likely to be created and captured.

Connected healthcare is built on four interconnected layers: devices, connectivity, platforms, and intelligence.

• Devices

   include regulated medical technologies such as continuous glucose monitors, cardiac monitors, connected infusion pumps, and ventilators, as well as clinical grade wearables, monitoring patches, and consumer devices that increasingly incorporate validated health capabilities.

• Connectivity

   includes hospital networks, home broadband, cellular networks, and private 5G infrastructure, supported by growing investment in medical device cybersecurity and secure data exchange.

• Platforms

   collect and integrate device data with electronic health records, support care team workflows, and enable services such as remote patient monitoring, virtual wards, and hospital at home programs.

• Intelligence

   uses AI and analytics to identify deterioration risks, detect arrhythmias, support glycemic management, assess fall risk, improve treatment adherence, and generate actionable clinical insights from continuous data streams.

Three care models are being transformed by these technologies:

• Remote monitoring and virtual wards

  , which extend clinical oversight into the home for patients recovering from hospitalization or managing chronic conditions.

• Hospital at home programs

  , which deliver acute care services, including monitoring, infusions, nursing support, and physician oversight, within the patient's home environment.

• Smart hospitals

  , which connect beds, pumps, monitors, staff, and assets to improve operational efficiency, patient flow, capacity management, and clinical coordination.

The economic model is also evolving. Healthcare organizations and payers are increasingly focused on outcomes rather than device purchases alone. Connected care programs are being evaluated on their ability to reduce hospital admissions, lower readmission rates, improve patient outcomes, and support more efficient care delivery. As a result, value is increasingly shifting toward platforms and care models that convert continuous monitoring data into measurable clinical and operational improvements.

The convergence of connected devices, healthcare platforms, and AI is enabling earlier interventions, improved patient monitoring, and care delivery beyond traditional clinical settings, helping move healthcare closer to continuous and proactive care.

The connected healthcare market, including connected medical devices and wearables, remote monitoring platforms, hospital at home solutions, smart hospital infrastructure, device security, and integration services, is estimated at USD 60–80 billion in 2026. Current adoption is led by continuous glucose monitoring, cardiac monitoring, remote management of chronic conditions, and connected equipment deployed across healthcare facilities.

Meticulous Next™ expects the market to reach USD 220–300 billion by 2034, representing an indicative CAGR of 17–20%. Compared with software driven healthcare categories, market growth is expected to be more gradual because a significant share of the market consists of regulated medical devices that operate within longer development, approval, and reimbursement cycles.

Growth is being driven by:

• Expansion of hospital at home and virtual ward reimbursement programs.

• Increasing adoption of AI enabled continuous monitoring in acute and chronic care settings.

• Growing investment in smart hospital infrastructure and connected clinical environments.

• Rising demand for proactive and preventive care models supported by continuous monitoring.

Over the forecast period, market activity is expected to shift from standalone devices toward integrated platforms, managed services, and outcome linked care models that combine devices, data, and clinical workflows.

Regionally:

• North America

   is expected to lead adoption through reimbursement supported remote monitoring and connected care programs.

• The United Kingdom and Europe

   are expected to lead the development of virtual wards and nationally supported connected care initiatives.

• Asia Pacific

   is expected to expand rapidly through ageing populations, increasing digital health investment, and widespread adoption of consumer health wearables.

The long term opportunity lies not only in connected devices, but in the platforms, services, and care models that transform continuous data into measurable clinical and operational outcomes.

The base case assumes hospital-at-home and remote-monitoring reimbursement expands steadily and health systems invest in integration and security. An accelerated case adds workforce shortages and capacity crises that force care outside the hospital and rapid reimbursement reform, pulling the inflection to ~2028 and the 2034 value to the top of the range. A delayed case assumes reimbursement stalls, integration and security burdens slow deployment, or clinical evidence disappoints, pushing the inflection to ~2031 and confining growth to device-led monitoring.

Growth drivers

• Capacity and workforce pressure: ageing populations, chronic-disease prevalence and staff shortages exceed hospital capacity, and monitored care outside the hospital is the only scalable response.
• Reimbursement: hospital-at-home, remote monitoring and virtual-ward payment frameworks are expanding in major markets.
• Clinical evidence: continuous monitoring and early intervention reduce admissions, readmissions and length of stay.
• Consumer adoption: wearables with validated health functions bring continuous data to populations at scale.

Enablers

• Clinical-grade continuous sensors and wearables at consumer price points.
• Care platforms integrating devices, records, AI triage and virtual care.
• Home and hospital connectivity, including private 5G and reliable home broadband.
• Device-cybersecurity and interoperability standards, including FHIR and device-data profiles.

Restraints and barriers

• Integration: device data often stays in vendor silos rather than records and workflows.
• Security and regulation: connected devices expand the attack surface and face tightening cybersecurity requirements.
• Reimbursement variability across markets and payers.
• Clinical workflow, alert burden and liability for continuous data.

Five converging forces will determine the pace and scale at which connected healthcare reshapes care delivery:

• Hospital capacity constraints and workforce pressures

  , driving demand for care models that extend monitoring and treatment beyond traditional healthcare settings.

• Reimbursement support for monitored care outside the hospital

  , including remote patient monitoring, virtual wards, and hospital at home programs.

• The maturity of connected care platforms

  , particularly those that integrate devices, electronic health records, and AI driven analytics.

• Device cybersecurity and interoperability requirements

  , shaping how connected devices are deployed, managed, and integrated across healthcare systems.

• The advancement of consumer grade sensors toward clinical validity

  , expanding the range of health data that can be used for medical monitoring and decision making.

The brief assesses each of these forces in terms of direction, pace of adoption, and confidence level.

The key players operating in connected healthcare include Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Abbott Laboratories, Dexcom Inc., Masimo Corporation, Omron Corporation, ResMed Inc., Baxter International Inc., Stryker Corporation, Boston Scientific Corporation, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Apple Inc., Samsung Electronics Co. Ltd., Alphabet Inc. (Google, Fitbit), Oura Health Oy, Garmin Ltd., Whoop Inc., Withings, BioIntelliSense Inc., Biofourmis, Vivalink Inc., Huma Therapeutics Ltd., Dozee, DarioHealth Corp., Teladoc Health Inc., Best Buy Health, Epic Systems Corporation, Oracle Corporation (Oracle Health), Microsoft Corporation, Amazon Web Services, Cisco Systems Inc., Zebra Technologies Corporation, Securitas Healthcare and Health Catalyst Inc. The brief profiles representative players in each archetype and assesses which are positioned to own the connected-care platform.

The competitive landscape is forming around six archetypes. Medical-device and monitoring companies supply regulated connected devices and clinical-grade wearables. Consumer-health and wearable makers bring continuous data at population scale with expanding clinical functions. Remote-monitoring, virtual-ward and hospital-at-home platforms run monitored care as a service. Health-IT and EHR vendors integrate device data into records and workflows. Smart-hospital connectivity, asset-tracking and security providers instrument the building and secure devices. Health systems, payers and retail-health entrants build monitored-care models. Competitive intensity is moderate in 2026 and is expected to rise as care platforms compete with device makers and EHR vendors for the integration layer.

In 2026 value sits in connected devices and consumer wearables. By 2029 it moves to care platforms that run virtual wards, hospital-at-home and chronic-care monitoring under reimbursement, and to smart-hospital infrastructure and security. By 2034 it settles in care platforms that integrate devices, records and AI across settings, device makers with clinical-grade continuous data embedded in those platforms, and health systems and payers whose monitored-care models deliver outcomes at lower cost. Device makers that sell sensors without care models are commoditized; health systems that keep care visit-based lose patients and margin to monitored-care providers.

Investment activity is increasingly concentrated in remote monitoring platforms, virtual ward solutions, hospital at home providers, and clinical grade wearable technologies. Medical device companies, health IT providers, and retail health organizations are expanding their capabilities through acquisitions, partnerships, and platform investments as monitored care becomes a larger component of healthcare delivery. At the same time, health systems are investing in smart hospital infrastructure and integration programs, while payers are increasingly supporting care models linked to measurable outcomes outside traditional hospital settings.

Innovation activity is focused on several key areas:

• Continuous physiological monitoring and sensing technologies.

• AI models for deterioration detection and risk prediction.

• Closed loop monitoring and device control systems.

• Medical device cybersecurity.

• Interoperability and data integration across healthcare systems.

The brief tracks four key indicators:

• The number of patients enrolled in remote monitoring and hospital at home programs across major markets.

• The share of device generated data integrated into clinical records and care workflows.

• Reimbursement coverage for monitored and connected care services.

• Consolidation activity involving monitoring platforms, medical device companies, and health IT providers.

Regionally:

• North America

   leads adoption through reimbursement supported remote monitoring and hospital at home programs, supported by major health systems, device manufacturers, and platform providers.

• The United Kingdom and Europe

   are advancing through virtual ward initiatives, national healthcare programs, and governance frameworks including the Medical Device Regulation, AI Act, and health data policies.

• Asia Pacific

   is expanding through ageing populations, digital health investment, and increasing adoption of consumer and clinical wearables, particularly in Japan, Singapore, Australia, India, and China.

The brief assesses how investment activity, reimbursement models, technology adoption, and regulatory developments are shaping the evolution of connected and continuously monitored healthcare.